Takuji TOMIMATSU

Dr. Takuji TOMIMATSU


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
TTTakuji TOMIMATSU
Takuji TOMIMATSU
KMKazuya Mimura
Kazuya Mimura
Shinya MatsuzakiShinya Matsuzaki
Shinya Matsuzaki
MEMasayuki Endo
Masayuki Endo
KKKeiichi Kumasawa
Keiichi Kumasawa
TKTadashi Kimura
Tadashi Kimura
Preeclampsia, a systemic vascular disorder characterized by new-onset hypertension and proteinuria after 20 weeks of gestation, is the leading cause of maternal and perinatal morbidity and mortality. Maternal endothelial dysfunction caused by placental factors has long been accepted with respect to the pathophysiology of preeclampsia. Over the past decade, increased production of placental antiangiogenic factors has been identified as a placental factor leading to maternal endothelial dysfunction and systemic vascular dysfunction. This review summarizes the recent advances in understanding the molecular mechanisms of endothelial dysfunction caused by placental antiangiogenic factors, and the novel clinical strategies based on these discoveries.

2 February 2012 in Hypertension Research
Verified
Journal Article
Closed access
MFMika Fujime
Mika Fujime
TTTakuji TOMIMATSU
Takuji TOMIMATSU
YOYuko Okaue
Yuko Okaue
SKShinsuke Koyama
Shinsuke Koyama
TKTakeshi Kanagawa
Takeshi Kanagawa
TKTadashi Kimura
Tadashi Kimura

16 December 2019 in BMC Surgery
Verified
Journal Article
Open access
PDF file
Shinya MatsuzakiShinya Matsuzaki
Shinya Matsuzaki
MJMariko Jitsumori
Mariko Jitsumori
THTakeya Hara
Takeya Hara
SMSatoko Matsuzaki
Satoko Matsuzaki
SNSatoshi Nakagawa
Satoshi Nakagawa
TKTadashi Kimura
Tadashi Kimura
Background: This study aimed to identify and review associations between the types of sutures used for uterine compression suture (UCS) and its outcomes in postpartum hemorrhage.Methods: An electronic search using PubMed and Scopus databases was performed. We included the English articles reported from January 1, 1997, to May 31, 2017, using search words or terms regarding the types of suture and needle used for UCSs. We only included studies describing the sutures in the systematic review.Results: We found 196 studies and included 76 (38.8%) in our analysis. We collected data on maternal outcomes for 924 patients and categorized them. Of the 76 studies, suture sizes 0, 1, and 2 were used in 6, 44, and 32 articles, respectively (some studies used multiple sutures). Of the 45 studies mentioning the needles, curved and straight needles were used in 35 and 10, respectively. The results of our review revealed that about 80% of previous articles used Catgut and Polyglactin 910 sutures. Because no studies that compared the efficacy of different size of sutures were identified, we investigated the differences using the cases reported in previous studies mentioned above. In the first analysis, we compared the uterine preservation rate between size 1 and size 2 sutures. We found no significant difference in uterine preservation rate (92.8%: size 1 vs. 94.2%: size 2,p > 0.05) but found significant difference in transfusion rate (62.4% vs. 79.1%,p < 0.01). With the hypothesis that non-transfusion cases were less severe, we excluded these cases from second analysis. Although our second analysis of only Catgut or Polyglactin showed strong selection bias, we observed that uterine preservation rate was significantly higher in cases with size 2 suture than in those with size 1 suture (86.9% vs. 93.5%,p = 0.033).Conclusions: Our systematic review showed that approximately 80% of cases were treated by Catgut and Polyglactin 910. Due to the heterogeneity of cases included in this review, it is difficult to estimate which suture is better for UCSs. More robust studies are necessary to enable the identification of the superior suture for performing UCSs.

30 December 2011 in Reproductive Sciences
Verified
Journal Article
Closed access
PDF file
KMKazuya Mimura
Kazuya Mimura
TTTakuji TOMIMATSU
Takuji TOMIMATSU
KMKenji Minato
Kenji Minato
OJOtgonbaatar Jugder
Otgonbaatar Jugder
YKYukiko Kinugasa-Taniguchi
Yukiko Kinugasa-Taniguchi
TKTadashi Kimura
Tadashi Kimura

24 January 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
YKYoko Kawanishi
Yoko Kawanishi
AKAiko Kakigano
Aiko Kakigano
TKTakashi Kimura
Takashi Kimura
SISatoyo Ikehara
Satoyo Ikehara
TSTakuyo Sato
Takuyo Sato
OGon behalf of the Japan Environment and Children’s Study Group
on behalf of the Japan Environment and Children’s Study Group
Background: The association between coffee/tea intake and hypertensive disorders of pregnancy (HDP) remains unclear. This study aimed to investigate the association of caffeine, coffee, and tea intake during pregnancy with the risk of HDP. Methods: We assessed this association in 85,533 singleton pregnant women with live births in the Japan Environment and Children’s Study, a prospective cohort in Japan that included women from early pregnancy onward. Caffeinated and decaffeinated coffee and tea (green, oolong, and black) consumption during pregnancy was assessed using a validated food frequency questionnaire conducted at mid-pregnancy, and caffeine intake was calculated based on coffee and tea consumption. Multivariable logistic regression was used to assess the association with the risk of HDP. Results: HDP developed in 2222 women (2.6%). Caffeine intake was weakly associated with increased risk of HDP; the multivariable odds ratio of HDP for the highest versus the lowest quartile was 1.26 (95% confidence interval: 1.11, 1.43). Coffee drinkers of two or more cups per day showed a decreased risk compared with non-drinkers (multivariable odds ratio 0.79; 0.62, 0.99) even after adjustment for total caffeine intake. Tea consumption was not associated with the risk of HDP. Conclusions: Our study suggests that higher caffeine intake may increase HDP risk, while coffee drinkers had a lower risk. Further high-quality studies are needed to replicate these findings, and to elucidate if other substances in coffee may be protective against HDP.

28 November 2021 in Diagnostics
Verified
Journal Article
Open access
PDF file
THTakeya Hara
Takeya Hara
KMKazuya Mimura
Kazuya Mimura
MEMasayuki Endo
Masayuki Endo
MFMakoto Fujii
Makoto Fujii
TMTatsuya Matsuyama
Tatsuya Matsuyama
TKTadashi Kimura
Tadashi Kimura
Background: Fetal ovarian cysts are the most frequently diagnosed intra-abdominal cysts; however, the evidence for perinatal management remains controversial. Methods: We retrospectively reviewed cases of fetal ovarian cysts diagnosed by prenatal ultrasonography at our institution between January 2010 and January 2020. The following were investigated: gestational age at diagnosis, cyst size, appearance, prenatal ultrasound findings, and postnatal outcomes. Prior to 2018, expectant management was applied in all cases; after 2018, in utero aspiration (IUA) of simple cysts ≥40 mm was performed. Results: We diagnosed 29 and seven simple and complex cysts, respectively. Fourteen patients had simple cysts with a maximum diameter <40 mm, and two of them progressed to complex cysts during follow-up; however, when the diameter was limited to <35 mm, no cases showed progression to complex cyst. Fifteen of the simple cysts were ≥40 mm; three progressed to complex cysts, and two of them were confirmed to be ovarian necrosis. In four patients who underwent IUA, the ovaries could be preserved. Conclusions: IUA is a promising therapy for preserving ovaries with simple cysts ≥40 mm in diameter; however, the indications for fetal surgery and the appropriate timing of intervention require further study.